Trendingnow
Big Tech

By Norah Rami, Matthew Griffin and BloombergAugust 29, 2026

Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine
By Avalon Pernell, Lisa Pham and BloombergAugust 29, 2026

Latest stories from Fortune
More Big TechPage 22 of 73

By Kaitlyn Huamani, Barbara Ortutay and The Associated PressMarch 25, 2026

By Sharon GoldmanMarch 25, 2026

By Kamal AhmedMarch 25, 2026

By Thalia Beaty and The Associated PressMarch 25, 2026

By Barbara Ortutay, Kaitlyn Huamani and The Associated PressMarch 25, 2026

By Nicholas GordonMarch 25, 2026

By Claire ZillmanMarch 24, 2026

By The Associated Press and Morgan LeeMarch 23, 2026

By Carlos GarciaMarch 23, 2026

By Amanda GerutMarch 23, 2026

By Thomas Buckley and BloombergMarch 22, 2026

By Kara Carlson, Loren Grush and BloombergMarch 22, 2026

By Liza Tetley and BloombergMarch 21, 2026

By Sasha RogelbergMarch 21, 2026

By Sheryl EstradaMarch 21, 2026

By Isaiah Poritz, Jef Feeley and BloombergMarch 20, 2026

By Marco Quiroz-GutierrezMarch 20, 2026

By The Associated Press and Travis LollerMarch 20, 2026

By Marco Quiroz-GutierrezMarch 20, 2026

The $3.4 billion lesson Big Pharma needs to learn: its shelved drugs could save millions of patients
By Annette Bakker and Andrew W. LoMarch 19, 2026

By Jake AngeloMarch 19, 2026

Today’s Bob Iger’s last day leading Disney. Here’s what comes next at the company worth $176 billion
By Jacqueline MunisMarch 18, 2026

By Beatrice NolanMarch 18, 2026

By Jim EdwardsMarch 18, 2026

By Eva RoytburgMarch 17, 2026

By Jake AngeloMarch 17, 2026

By Sharon GoldmanMarch 17, 2026
Most Popular
















